Unio Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Sell
27,900
-75
-0.3% -$76.6K 6.36% 9
2026
Q1
$25.7M Sell
27,975
-1,354
-5% -$1.37M 5.52% 9
2025
Q4
$31.5M Sell
29,329
-2,498
-8% -$2.39M 5.93% 9
2025
Q3
$24.3M Buy
31,827
+6,634
+26% +$4.94M 5.79% 7
2025
Q2
$19.6M Buy
25,193
+5,313
+27% +$4.13M 5.78% 6
2025
Q1
$16.4M Sell
19,880
-626
-3% -$521K 6.3% 4
2024
Q4
$15.8M Buy
+20,506
New +$17M 5.66% 6
2024
Q1
Sell
-9,668
Closed -$5.64M 39
2023
Q4
$5.64M Sell
9,668
-1,401
-13% -$818K 2.88% 20
2023
Q3
$5.95M Sell
11,069
-4,574
-29% -$2.36M 3.22% 18
2023
Q2
$7.34M Sell
15,643
-4,286
-22% -$1.8M 3.74% 13
2023
Q1
$6.84M Sell
19,929
-355
-2% -$120K 3.66% 13
2022
Q4
$7.42M Sell
20,284
-881
-4% -$312K 4.12% 9
2022
Q3
$6.84M Sell
21,165
-122
-0.6% -$38.7K 4.13% 9
2022
Q2
$6.9M Buy
+21,287
New +$6.39M 3.97% 12

Other funds holding LLY

Unio Capital's LLY Position: Q2 2026 in Review

Unio Capital reduced its Eli Lilly (LLY) stake by 0.27% in Q2 2026, selling an estimated $76.6K and leaving 27,900 shares worth $33.5M. The position accounts for 6.36% of the portfolio, ranked #9.

Unio Capital first reported a position in LLY in Q2 2022 and has held it in 14 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Unio Capital held 27,900 shares of Eli Lilly worth $33.5M as of Q2 2026.
  • Unio Capital sold 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
  • Eli Lilly made up 6.36% of Unio Capital's portfolio in Q2 2026, its #9 holding.
  • Unio Capital first reported a position in Eli Lilly in Q2 2022 and has held it in 14 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Unio Capital's 13F filing for Q2 2026, filed 14 Aug 2026.